714
Views
26
CrossRef citations to date
0
Altmetric
Review Article

The clinical role of well-being therapy

, &
Pages 447-453 | Received 26 Feb 2018, Accepted 29 May 2018, Published online: 16 Nov 2018

References

  • Fava GA, Rafanelli C, Tomba E. The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry. 2012;73:177–184.
  • Fava GA. Clinical judgment in psychiatry. Requiem or reveille? Nord J Psychiatry. 2013;67:1–10.
  • Rafanelli C, Park SK, Ruini C, et al. Rating well-being and distress. Stress Med. 2000;16:55–61.
  • Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother Psychosom. 2017;86:13–30.
  • Thunedborg K, Black CH, Bech P. Beyond the hamilton depression scores in longterm treatment of manic-melancholic patients: prediction of recurrence of depression by quality of life measurements. Psychother Psychosom. 1995;64:131–140.
  • Wood AM, Joseph S. The absence of positive psychological (eudemonic) well-being as a risk factor for depression: a ten year cohort study. J Affect Disord. 2010;122:213–217.
  • Fava GA, Ruini C, Belaise C. The concept of recovery in major depression. Psychol Med. 2007;37:307–317.
  • Fava GA, Bech P. The concept of euthymia. Psychother Psychosom. 2016;85:1–5.
  • Fava GA. Sequential treatment: a new way of integrating pharmacotherapy and psychotherapy. Psychother Psychosom. 1999;68:227–229.
  • Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 2016;173:128–137.
  • Brakemeier E-L, Merkl A, Wilbertz G, et al. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biol Psychiatry. 2014;76:194–202.
  • Bech P. Clinical psychometrics. Oxford, UK: Wiley-Blackwell; 2012.
  • Bech P. Clinimetric dilemmas in outcome scales for mental disorders. Psychother Psychosom. 2016;85:323.
  • Hasler G. Well-being: an important concept for psychotherapy and psychiatric neuroscience. Psychother Psychosom. 2016;85:255–261.
  • Fava GA, Tomba E, Bech P. Clinical pharmacopsychology: conceptual foundations and emerging tasks. Psychother Psychosom. 2017;86:134–140.
  • Fava GA. Well-being therapy: conceptual and technical issues. Psychother Psychosom. 1999;68:171–179.
  • Fava GA. Well-being therapy treatment manual and clinical applications. Basel: Karger; 2016.
  • Fava GA, Cosci F, Guidi J, et al. Well-being therapy in depression: new insights into the role of psychological well-being in the clinical process. Depress Anxiety. 2017;34:801–808.
  • Jahoda M. Current concepts of positive mental health. New York, NY, US: Basic Books; 1958.
  • Ryff CD. Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychother Psychosom. 2014;83:10–28.
  • Fava GA, Rafanelli C, Cazzaro M, et al. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med. 1998;28:475–480.
  • Fava GA, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998;55:816–820.
  • Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161:1872–1876.
  • Stangier U, Hilling C, Heidenreich T, et al. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial. Am J Psychiatry. 2013;170:624–632.
  • Kennard BD, Emslie GJ, Mayes TL, et al. Sequential treatment with fluoxetine and relapse-prevention CBT to improve outcomes in pediatric depression. Am J Psychiatry. 2014;171:1083–1090.
  • Farb N, Anderson A, Ravindran A, et al. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy. J Consult Clin Psychol. 2018;86:200–204.
  • Moeenizadeh M, Salagame KK. The impact of well—being therapy on symptoms of depression. IJPS. 2010;2:223–230.
  • Fava GA, Ruini C, Rafanelli C, et al. Well-being therapy of generalized anxiety disorder. Psychother Psychosom. 2005;74:26–30.
  • Fava GA, Tomba E. Increasing psychological well-being and resilience by psychotherapeutic methods. J Pers. 2009;77:1903–1934.
  • Emmelkamp P, Bouman T, Scholing A. Anxiety disorders: a practitioner’s guide. Chichester, UK: John Wiley & Sons, Ltd; 1992.
  • Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013;82:20–34.
  • Guidi J, Tomba E, Cosci F, et al. The role of staging in planning psychotherapeutic interventions in depression. J Clin Psychiatry. 2017;78:456–463.
  • Csikszentmihalyi M, Csikszentmihalyi IS. Optimal experience: psychological studies of flow in consciousness. New York, NY: Cambridge University Press; 1988.
  • Beck A, Rush A, Shaw B, et al. Cognitive therapy of depression. New York: The Guilford Press; 1979.
  • Guidi J, Fava GA, Bech P, et al. The clinical interview for depression: a comprehensive review of studies and clinimetric properties. Psychother Psychosom. 2011;80:10–27.
  • Fava GA, Rafanelli C, Tomba E, et al. The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom. 2011;80:136–143.
  • Tomba E, Tecuta L, Guidi J, et al. Demoralization and response to psychotherapy: a pilot study comparing the sequential combination of cognitive-behavioral therapy and well-being therapy with clinical management in cyclothymic disorder. Psychother Psychosom. 2016;85:56–57.
  • Garamoni GL, Reynolds CF, Thase ME, et al. The balance of positive and negative affects in major depression: a further test of the States of Mind model. Psychiatry Res. 1991;39:99–108.
  • Wood AM, Tarrier N. Positive clinical psychology: a new vision and strategy for integrated research and practice. Clin Psychol Rev. 2010;30:819–829.
  • Huijbregts KM, Hoogendoorn AW, Slottje P, et al. Long-term and short-term antidepressant use in general practice: data from a large cohort in the Netherlands. Psychother Psychosom. 2017;86:362–369.
  • Cosci F. Well-being therapy in a patient with panic disorder who failed to respond to paroxetine and cognitive behavior therapy. Psychother Psychosom. 2015;84:318–319.
  • Sonino N, Fava GA. Tolerance to antidepressant treatment may be overcome by ketoconazole. Report of two cases. J Psychiatr Res. 2003;37:171–173.
  • Meulenbeek P, Christenhusz L, Bohlmeijer E. Well-being therapy in the Netherlands. Psychother Psychosom. 2015;84:316–317.
  • Tomba E, Tecuta L. Well-being therapy in a patient with anorexia nervosa. Psychother Psychosom. 2016;85:369–370.
  • Belaise C, Fava GA, Marks IM. Alternatives to debriefing and modifications to cognitive behavior therapy for posttraumatic stress disorder. Psychother Psychosom. 2005;74:212–217.
  • Vazquez C, Pérez-Sales P, Ochoa C. Post-traumatic growth. In: Fava GA, Ruini C, editors. Increasing psychological well-being in clinical and educational settings Intervention and cultural contexts. Dordrecht: Springer; 2014. p. 57–74.
  • Chouinard G, Chouinard V-A. New classification of selective serotonin reuptake inhibitor withdrawal. Psychother Psychosom. 2015;84:63–71.
  • Chouinard G, Samaha A-N, Chouinard V-A, et al. Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy. Psychother Psychosom. 2017;86:189–219.
  • Fava GA, Cosci F, Offidani E, et al. Behavioral toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment. J Clin Psychopharmacol. 2016;36:550–553.
  • Belaise C, Gatti A, Chouinard V-A, et al. Persistent postwithdrawal disorders Induced by paroxetine, a selective serotonin reuptake inhibitor, and treated with specific cognitive behavioral therapy. Psychother Psychosom. 2014;83:247–248.
  • Chopin M-V, Peretti C-S, Gisquet-Verrier P, et al. Cocaine use disorder treated with specific cognitive behavioral therapy and adjunctive propranolol. Psychother Psychosom. 2016;85:61–63.
  • Cole SW. Human social genomics. PLoS Genet. 2014;10:e1004601.
  • Currier MB, Nemeroff CB. Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu Rev Med. 2014;65:203–221.
  • Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak—the link between depression and cardiovascular disease. Nat Rev Cardiol. 2012;9:526–539.
  • Fredrickson BL, Grewen KM, Algoe SB, et al. Psychological well-being and the human conserved transcriptional response to adversity. PLoS One. 2015;10:e0121839.
  • Horwitz RI, Hayes-Conroy A, Singer BH. Biology, social environment, and personalized medicine. Psychother Psychosom. 2017;86:5–10.
  • Sirri L, Fava GA, Sonino N. The unifying concept of illness behavior. Psychother Psychosom. 2013;82:74–81.
  • Quoidbach J, Mikolajczak M, Gross JJ. Positive interventions: an emotion regulation perspective. Psychol Bull. 2015;141:655–693.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.